The global antifungal agents market is anticipated to grow at a considerable CAGR of nearly 3.5% during the forecast period (2021-2027). The factor contributing to the growth of antifungal agents include the rise in the number of COVID-19 cases and diabetic patients. Moreover, due to COVID-19, there is an increase in the number of viral infections and […]
Category Archives: Pharmaceuticals
The global animal vaccine market is anticipated to grow at a considerable CAGR of 6.8% during the forecast period (2021-2027). The market growth is mainly attributed to the introduction of new animal vaccines and approval of the animal vaccine by the key market players, such as Boehringer Ingelheim, Elanco, Merck, and Zoetis Inc. For instance, in January […]
The Asia-Pacific OTC drugs market is anticipated to grow at a CAGR of 7.9% during the forecast period. The market growth is attributed to the increasing trend of self-medication in the region coupled with the increasing healthcare spending. Major economies covered in the study of the Asia-Pacific OTC drugs industry report covers the analysis of […]
The US schizophrenia drugs market is projected to grow at a significant CAGR of 2.7% during the forecast period (2020-2026). The rising awareness programs for mental health is acting as one prominent factor in the market growth in the US. The first Wednesday in November each year is celebrated as National Stress Awareness Day in […]
UK schizophrenia drug market is projected to grow at a significant CAGR of around 2.7% during the forecast period (2020-2026). UK has a well-developed healthcare infrastructure with an established mental health facility. National Health Services (NHS) England spends $7.2 million per year on mental health services for ex-service personnel, in addition to the $12.7 billion […]
North American schizophrenia drugs market is projected to grow at a significant CAGR of 2.1% during the forecast period (2020-2026). The increasing incidence of anxiety disorders in North America is generating the demand for different types of medication and therapies for its treatment and thereby is expected to propel the growth of the schizophrenia drugs […]
The European schizophrenia drug market is projected to grow at a significant CAGR of around 2.5% during the forecast period (2020-2026). The availability of considerable resources for mental health and a sophisticated healthcare system are other key factors that are expected to promote the growth of the market. In the UK, Mental Health First Aid […]
Asia-Pacific schizophrenia drugs market is projected to grow at a significant CAGR of 3.6% during the forecast period (2020-2026). In Asia-Pacific, the schizophrenia has a high prevalence in South Asian countries as compared to the rest of the region. According to the Progress in Mind, there are significantly different medication patterns preferred across South Asian […]
Indian schizophrenia drugs market is projected to grow at a significant CAGR of 4.0% during the forecast period (2020-2026). The major contributors in the market are the female population suffering from mental health issues in the country. There is no gender difference in schizophrenia; however, a stress and mental health are some factors leads to […]
France urothelial carcinoma market is estimated to grow considerably, at a CAGR of around 9.6% during the forecast period. France is one of the leading economies and technologically advanced countries in Europe. France has a quality healthcare system and favorable government policies which is augmenting the growth of the market in France. The number of […]